NUS

MKT CAP:$361M

Nu Skin Enterprises, Inc.

Market Cap

$361M

Consumer Defensive·Household & Personal Products·🇺🇸 United States·NYSE

Consumer Def.·Household·🇺🇸·NYSE

Stock Price

$7.54-$2.15 (-22.19%)

Apr 24, 2026

Company Details

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment an...

CEO

Ryan S. Napierski

IPO Date

Nov 22, 1996

Website

www.nuskin.com

Key Metrics TTM

Revenue

$1.5B

-14.3% YoY

Net Income

$160M

EPS (Diluted)

$3.20

Free Cash Flow

$46M

Revenue / Share

$29.76

Gross Margin

69.4%

Operating Margin

4.4%

Net Margin

10.8%

FCF Margin

3.1%

P/S

0.2x

P/E

2.3x

Earnings Reports

Q1 2026

May 14, 2026

PENDING

FY 2025

Feb 12, 2026

$1.5B-14.3%EPS $3.18

Q4 2025

Feb 12, 2026

$370M-16.9%EPS $0.29

Q3 2025

Nov 6, 2025

$364M-15.3%EPS $0.34

Q2 2025

Aug 7, 2025

$386M-12.1%EPS $0.43

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$605M	$443M	$52M
Q2 22	$561M	$413M	$52M
Q3 22	$538M	$364M	-$20M
Q4 22	$522M	$375M	$27M
Q1 23	$481M	$348M	$16M
Q2 23	$500M	$365M	$43M
Q3 23	$499M	$292M	-$26M
Q4 23	$489M	$352M	$16M
Q1 24	$417M	$294M	$9M
Q2 24	$439M	$307M	-$126M
Q3 24	$430M	$301M	$18M
Q4 24	$446M	$279M	-$53M
Q1 25	$364M	$247M	-$10M
Q2 25	$386M	$266M	$31M
Q3 25	$364M	$257M	$22M
Q4 25	$370M	$262M	$23M

Valuation

Quarter	P/S	P/E
Q1 22	0.1x	2.6x
Q2 22	0.1x	3.2x
Q3 22	0.2x	9.4x
Q4 22	0.2x	3.4x
Q1 23	0.2x	4.7x
Q2 23	0.2x	5.1x
Q3 23	0.2x	6.2x
Q4 23	0.2x	42.0x
Q1 24	0.2x	—
Q2 24	0.2x	—
Q3 24	0.2x	—
Q4 24	0.2x	—
Q1 25	0.2x	—
Q2 25	0.2x	3.6x
Q3 25	0.2x	3.3x
Q4 25	0.2x	2.3x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	$8M	-$3M
Q2 22	$47M	$37M
Q3 22	$28M	$3M
Q4 22	$26M	$12M
Q1 23	-$22M	-$34M
Q2 23	$36M	$21M
Q3 23	$51M	$39M
Q4 23	$54M	$34M
Q1 24	$3M	-$9M
Q2 24	$51M	$43M
Q3 24	$31M	$23M
Q4 24	$26M	$13M
Q1 25	$389.0K	-$13M
Q2 25	$36M	$36M
Q3 25	$27M	$18M
Q4 25	$17M	$6M

Capital Expenditures

Quarter	CapEx
Q1 22	$10M
Q2 22	$10M
Q3 22	$25M
Q4 22	$14M
Q1 23	$11M
Q2 23	$15M
Q3 23	$12M
Q4 23	$20M
Q1 24	$12M
Q2 24	$8M
Q3 24	$9M
Q4 24	$13M
Q1 25	$14M
Q2 25	$18.0K
Q3 25	$10M
Q4 25	$11M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	-10.7%	-10.0%
Q2 22	-20.4%	-17.7%
Q3 22	-16.1%	-3.1%
Q4 22	-22.4%	-24.2%
Q1 23	-20.4%	-15.8%
Q2 23	-10.8%	-10.1%
Q3 23	-7.3%	-5.9%
Q4 23	-6.5%	-4.5%
Q1 24	-13.3%	-12.2%
Q2 24	-12.2%	+23.4%
Q3 24	-13.8%	-21.6%
Q4 24	-8.8%	+5.5%
Q1 25	-12.7%	-8.3%
Q2 25	-12.1%	-37.1%
Q3 25	-15.3%	-16.8%
Q4 25	-16.9%	-30.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$4M	0.7%
Q2 22	$2M	0.4%
Q3 22	$3M	0.6%
Q4 22	$3M	0.6%
Q1 23	$0	0.0%
Q2 23	$5M	1.0%
Q3 23	$4M	0.7%
Q4 23	$3M	0.6%
Q1 24	$4M	1.0%
Q2 24	$4M	0.8%
Q3 24	$3M	0.8%
Q4 24	$3M	0.8%
Q1 25	$9M	2.6%
Q2 25	$6M	1.5%
Q3 25	$6M	1.6%
Q4 25	$3M	0.9%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 22	—	$149M	$243M
Q2 22	—	$142M	$219M
Q3 22	—	$138M	$216M
Q4 22	—	$128M	$201M
Q1 23	—	$134M	$188M
Q2 23	—	$137M	$185M
Q3 23	—	$131M	$188M
Q4 23	$23M	$145M	$181M
Q1 24	—	$125M	$154M
Q2 24	—	$118M	$165M
Q3 24	—	$116M	$168M
Q4 24	$13M	$121M	$165M
Q1 25	—	$113M	$119M
Q2 25	—	$107M	$128M
Q3 25	—	$105M	$130M
Q4 25	$11M	$107M	$131M

Revenue Segments

Quarter	Manufacturing Segment	Nu Skin	Rhyz Other Segment
Q1 22	$40M	$564M	$241.0K
Q2 22	$38M	$522M	$290.0K
Q3 22	$41M	$496M	$538.0K
Q4 22	$30M	$490M	$3M
Q1 23	$36M	$442M	$4M
Q2 23	$46M	$449M	$6M
Q3 23	$50M	$438M	$11M
Q4 23	$50M	$424M	$15M
Q1 24	$50M	$355M	$12M
Q2 24	$51M	$371M	$16M
Q3 24	$52M	$357M	$21M
Q4 24	$48M	$362M	$35M
Q1 25	$55M	$306M	$3M

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$302M	$15M	$318M
Q2 22	$364M	$18M	$382M
Q3 22	$294M	$14M	$308M
Q4 22	$265M	$14M	$279M
Q1 23	$230M	$17M	$247M
Q2 23	$236M	$17M	$252M
Q3 23	$233M	$17M	$250M
Q4 23	$256M	$12M	$268M
Q1 24	$213M	$9M	$221M
Q2 24	$224M	$9M	$233M
Q3 24	$228M	$10M	$238M
Q4 24	$187M	$11M	$198M
Q1 25	$204M	$10M	$214M
Q2 25	$264M	$1M	$265M
Q3 25	$252M	$1M	$253M
Q4 25	$239M	$1M	$240M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	51M	+0.5%	-2.1%
Q2 22	51M	-0.2%	-1.2%
Q3 22	50M	-1.5%	-2.1%
Q4 22	50M	-0.8%	-2.0%
Q1 23	50M	+0.6%	-2.0%
Q2 23	50M	+0.2%	-1.6%
Q3 23	50M	-0.6%	-0.7%
Q4 23	49M	-0.8%	-0.6%
Q1 24	50M	+0.1%	-1.0%
Q2 24	50M	+0.3%	-0.9%
Q3 24	50M	+0.1%	-0.3%
Q4 24	50M	-0.0%	+0.5%
Q1 25	50M	+1.2%	+1.6%
Q2 25	49M	-1.6%	-0.4%
Q3 25	50M	+1.6%	+1.2%
Q4 25	50M	-0.8%	+0.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$131.5K	5K
Q2 22	$121.9K	5K
Q3 22	$116.9K	5K
Q4 22	$137.5K	4K
Q1 23	$126.7K	4K
Q2 23	$131.6K	4K
Q3 23	$131.3K	4K
Q4 23	$132.1K	4K
Q1 24	$112.8K	4K
Q2 24	$118.7K	4K
Q3 24	$116.3K	4K
Q4 24	$143.7K	3K
Q1 25	$117.6K	3K
Q2 25	$124.6K	3K
Q3 25	$117.5K	3K
Q4 25	$132.3K	3K

Revenue / Employee